Skip to content

Shattuck Labs, Inc. STTK Geographic — 2028

Similar metrics at other companies

Open Lending Corporation logo
LPROAustin, Texas — Number of operating leases
0.30.0%
RLJ Lodging Trust logo
RLJAustin, Texas — Total revenues
$12.08M-2.7%
Public Storage logo
PSAAustin — No. of Facilities
40+2.6%
Public Storage logo
PSAAustin — SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Gross
$363.48M+4.7%
Digital Realty logo
DLRAustin — Number Of Real Estate Properties
10.0%
Independence Realty Trust logo
IRTAustin Texas — Number Of Investments In Developing Real Estate
100%

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree.

The official record: Shattuck Labs, Inc.’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s geographic — 2028.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s geographic — 2028?
Shattuck Labs, Inc. (STTK) reported geographic — 2028 of $200K in Q4 2025.
What does geographic — 2028 mean?
Represents the financial performance or operational activity attributed to the company's geographic presence in Austin, Texas for the fiscal year 2028. This metric captures regional resource allocation, facility-related expenditures, or localized clinical development activities. It serves as a proxy for evaluating the company's footprint in key biotechnology innovation hubs.